Literature DB >> 19030736

Clinical presentation and renal evaluation of human visceral leishmaniasis (kala-azar): a retrospective study of 57 patients in Brazil.

Elizabeth F Daher1, Leandro F Evangelista, Geraldo B Silva Júnior, Rafael S A Lima, Eveline B Aragão, Germana A J C Arruda, Noemi M F Galeano, Rosa M S Mota, Rodrigo A Oliveira, Sônia L Silva.   

Abstract

Visceral leishmaniasis is an endemic disease caused by various species of Leishmania. We made a retrospective study of 57 consecutive patients with visceral leishmaniasis in Brazil. Patients with visceral leishmaniasis were identified using the registries of the São José Infectious Diseases Hospital. The sample was divided into two groups: patients with serum creatinine (Scr) <1.3mg/dL and Scr > or = 1.3mg/dL. We compared these two groups for differences in clinical manifestations and laboratory features. Patients' mean age was 28 +/- 18 years old; 74% were male. The main clinical symptoms and signs presented in the initial evaluation were: fever (97%), splenomegaly (96.4%), weight loss (95.5%), pallor (93.6%), cough (89.7%), hepatomegaly (87.2%), asthenia (83.3%), anorexia (82.9%) and vomiting (73.9%). Acute renal failure was found in 15 patients (26.3%) and eight of these patients had ARF before amphotericin B administration. The mean age was higher in the group with Scr > or =1.3mg/dL. Death occurred in three cases; all deaths occurred with Scr > or =1.3mg/dL. There were no significant differences in the frequencies of the clinical symptoms and signs between the two groups. The laboratory data and demographic characteristics were significantly worse in the Scr > or =1.3mg/dL group. Renal dysfunction is an important feature of this disease; it is associated with important morbidity and can increase mortality.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19030736     DOI: 10.1590/s1413-86702008000400015

Source DB:  PubMed          Journal:  Braz J Infect Dis        ISSN: 1413-8670            Impact factor:   1.949


  12 in total

1.  Lysis syndrome during therapy of visceral leishmaniasis.

Authors:  E N Liberopoulos; A A Kei; M S Elisaf
Journal:  Infection       Date:  2011-10-18       Impact factor: 3.553

2.  Risk factors for acute kidney injury in visceral leishmaniasis (Kala-Azar).

Authors:  Michelle J C Oliveira; Geraldo B Silva Júnior; Krasnalhia Lívia S Abreu; Natália A Rocha; Ana Valeska V Garcia; Luiz F L G Franco; Rosa M S Mota; Alexandre B Libório; Elizabeth F Daher
Journal:  Am J Trop Med Hyg       Date:  2010-03       Impact factor: 2.345

3.  Late diagnosis: a factor associated with death from visceral leishmaniasis in elderly patients.

Authors:  Marta Driemeier; Polliana Alvarenga de Oliveira; Angelita Fernandes Druzian; Laís Ferreira Lopes Brum; Elenir Rose Jardim Cury Pontes; Maria Elizabeth Cavalheiros Dorval; Anamaria Mello Miranda Paniago
Journal:  Pathog Glob Health       Date:  2015-08-10       Impact factor: 2.894

Review 4.  The balancing act: Immunology of leishmaniosis.

Authors:  Angela J Toepp; Christine A Petersen
Journal:  Res Vet Sci       Date:  2020-02-11       Impact factor: 2.534

5.  Acute kidney injury in patients with Visceral Leishmaniasis in Northwest Ethiopia.

Authors:  Workagegnehu Hailu; Rezika Mohamed; Helina Fikre; Saba Atnafu; Azeb Tadesse; Ermias Diro; Johan van Grienvsen
Journal:  PLoS One       Date:  2021-06-08       Impact factor: 3.240

6.  Predictive models for the diagnostic of human visceral leishmaniasis in Brazil.

Authors:  Tália S Machado de Assis; Ana Rabello; Guilherme L Werneck
Journal:  PLoS Negl Trop Dis       Date:  2012-02-28

Review 7.  Renal involvement in leishmaniasis: a review of the literature.

Authors:  Anna Clementi; Giorgio Battaglia; Matteo Floris; Pietro Castellino; Claudio Ronco; Dinna N Cruz
Journal:  NDT Plus       Date:  2011-03-21

8.  Multiple nodular lesions in spleen associated with visceral leishmaniasis: a case report of MRI-findings.

Authors:  Guoqun Mao; Guangzhao Yang; Yougen Cheng; Chi S Zee; Wenmin Huang; Weiyang Ni; Guanmin Meng; Zhilu Chen
Journal:  Medicine (Baltimore)       Date:  2014-12       Impact factor: 1.889

9.  Risk Factors of Inpatients Mortality of Visceral Leishmaniasis, Khartoum State, Sudan.

Authors:  Omaima Abdel Majeed Mohamed Salih; Abdelsalam M Nail; Gad Allah Modawe; Mohamed Osman Swar; Mohamed H Ahmed; Atif Khalil; Abdelsalam Basheir Satti; Nadir Abuzeid
Journal:  J Glob Infect Dis       Date:  2020-08-29

10.  Assessment of liver function test and associated factors among visceral leishmaniasis patients attending university of gondar leishmaniasis research and treatment center, Northwest Ethiopia.

Authors:  Hiwot Tezera Endale; Tiget Ayelgn Mengstie; Dilargachew Dessie Dawit; Rezika Mohammed; Gashaw Dessie; Kibur Hunie Tesfa
Journal:  PLoS One       Date:  2021-11-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.